Venture Capital Resilient For MedTech Even As Public Markets Wilt – Report
This article was originally published in The Gray Sheet
Executive Summary
The U.S. medical technology industry's access to private venture capital remained largely intact in the first half of 2008, despite a global credit crunch that has depressed public equity financing in the sector, according to a 1report by consulting firm Ernst & Young